Microbiota therapy acts via a regulatory T cell MyD88/RORγt pathway to suppress food allergy

Abdel-Gadir A, Stephen-Victor E, Gerber GK, Noval Rivas M, Wang S, Harb H, Wang L, Li N, Crestani E, Spielman S, Secor W, Biehl H, Dibendetto N, Dong X, Umetsu DT, Bry L, Rachid R, Chatila TA (2019) Nat Med. 2019 Jun. doi: 10.1038/s41591-019-0461-z. [Epub ahead of print]

Web URL: Read this and related abstracts on PubMed here

Abstract:

The role of dysbiosis in food allergy (FA) remains unclear. We found that dysbiotic fecal microbiota in FA infants evolved compositionally over time and failed to protect against FA in mice.

Infants and mice with FA had decreased IgA and increased IgE binding to fecal bacteria, indicative of a broader breakdown of oral tolerance than hitherto appreciated. Therapy with Clostridiales species impacted by dysbiosis, either as a consortium or as monotherapy with Subdoligranulum variabile, suppressed FA in mice as did a separate immunomodulatory Bacteroidales consortium. Bacteriotherapy induced expression by regulatory T (Treg) cells of the transcription factor ROR-γt in a MyD88-dependent manner, which was deficient in FA infants and mice and ineffectively induced by their microbiota. Deletion of Myd88 or Rorc in Treg cells abrogated protection by bacteriotherapy.

Thus, commensals activate a MyD88/ROR-γt pathway in nascent Treg cells to protect against FA, while dysbiosis impairs this regulatory response to promote disease.

FAB RESEARCH COMMENT:

See the sociated news article:

Gut bacteria changes a target to address food allergies, study finds

< 9 July 2019 - MedicalXpress - Unusual eating behaviors may be a new diagnostic indicator for autism

Bledsoe et al 2019 - Micronutrient Deficiencies Are Common in Contemporary Celiac Disease Despite Lack of Overt Malabsorption Symptoms >

Microbiota therapy acts via a regulatory T cell MyD88/RORγt pathway to suppress food allergy

Abstract:

FAB RESEARCH COMMENT:

Newsletter Signup

Useful Links

Contact Us

Important Notice